A European guideline for the investigation and management of chronic mesenteric ischaemia
offers a structured approach to the investigation and treatment of mesenteric vascular
disease.
1
Endovascular treatment is advocated.
1
An earlier guideline published by the European Society of Vascular Surgery in 2017
acknowledged that there may be a role for endovascular revascularisation of the inferior
mesenteric artery (IMA), but there was parity regarding its indication.
2
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Vascular and Endovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- European guidelines on chronic mesenteric ischaemia – clinical guidelines on the diagnosis and treatment of patients with chronic mesenteric ischaemia.United Eur Gastroenterol J. 2020; 8: 371-395
- Management of the diseases of mesenteric arteries and veins. Clinical practice guidelines of the European Society of Vascular Surgery (ESVS).Eur J Vasc Endovasc Surg. 2017; 53: 460-510
- Inferior mesenteric artery stenting as a novel treatment for chronic mesenteric ischemia in patients with an occluded superior mesenteric artery and celiac trunk.Eur J Vasc Endovasc Surg. 2014; 27: 21-23
- Stenting of stenotic mesenteric arteries for symptomatic chronic mesenteric ischaemia.VASA. 2012; 41: 425-431
Article info
Publication history
Published online: October 07, 2022
Accepted:
October 2,
2022
Received:
April 15,
2022
Identification
Copyright
© 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
